TP53 Codon 72 Polymorphism Contributes to Nasopharyngeal Cancer Susceptibility: A Meta-Analysis

Archives of Medical Research

Volumn 40, Issue 4, 2009, Pages 299-305

  Zhuo, Xian Lu ^a,b   Cai, Lei ^a   Xiang, Zhao Lan ^a   Zhuo, Wen Lei ^a   Wang, Yan ^a   Zhang, Xue Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Nasopharyngeal carcinoma; Polymorphism; TP53 codon 72

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; DATA ANALYSIS; DATA EXTRACTION; EMBASE; GENOTYPE; HOMOZYGOTE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; NASOPHARYNX CANCER; PROTEIN POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHILD; CODON; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 67650085193     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.03.006     Document Type: Article

References (38)

1. Gullo C., Low W.K., and Teoh G. Association of Epstein-Barr virus with nasopharyngeal carcinoma and current status of development of cancer-derived cell lines. Ann Acad Med Singapore 37 (2008) 769-777
2. Cheng Y.J., Hildesheim A., Hsu M.M., et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 10 (1999) 201-207
3. Jayaprakash V., Natarajan K.K., Moysich K.B., et al. Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occup Environ Med 65 (2008) 647-654
4. Zheng X., Yan L., Nilsson B., Eklund G., and Drettner B. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 33 (1994) 867-872
5. Key T.J., Schatzkin A., Willett W.C., Allen N.E., Spencer E.A., and Travis R.C. Diet, nutrition and the prevention of cancer. Public Health Nutr 7 (2004) 187-200
6. Bumroongkit K., Rannala B., Traisathit P., Srikummool M., Wongchai Y., and Kangwanpong D. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors. Cancer Genet Cytogenet 185 (2008) 20-27
7. Assumpcao J.G., Seidinger A.L., Mastellaro M.J., et al. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8 (2008) 357
8. Mahdavinia M., Bishehsari F., Verginelli F., et al. P53 mutations in colorectal cancer from northern Iran: relationships with site of tumor origin, microsatellite instability and K-ras mutations. J Cell Physiol 216 (2008) 543-550
9. Chang K.P., Hao S.P., Lin S.Y., et al. A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy. Laryngoscope 112 (2002) 2015-2019
10. Sun Y., Hegamyer G., Cheng Y.J., et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 89 (1992) 6516-6520
11. Khabir A., Sellami A., Sakka M., et al. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 6 (2000) 3932-3936
12. Ara S., Lee P.S., Hansen M.F., and Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18 (1990) 4961
13. Shen H., Solari A., Wang X., et al. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 11 (2004) 1115-1120
14. Bonafé M., Ceccarelli C., Farabegoli F., et al. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients. Clin Cancer Res 9 (2003) 4860-4864
15. Storey A., Thomas M., Kalita A., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
16. Wang Y.C., Lee H.S., Chen S.K., Chang Y.Y., and Chen C.Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35 (1999) 226-230
17. Yu M.W., Yang S.Y., Chiu Y.H., Chiang Y.C., Liaw Y.F., and Chen C.J. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29 (1999) 697-702
18. Mabrouk I., Baccouche S., El-Abed R., et al. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann NY Acad Sci 1010 (2003) 764-770
19. Rosenthal R. The "file drawer problem" and tolerance for null results. Psychol Bull 86 (1979) 638-641
20. Van Tornout J.M., Spruck III C.H., Shibata A., et al. Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC. Cancer Epidemiol Biomarkers Prev 6 (1997) 493-497
21. Birgander R., Själander A., Zhou Z., Fan C., Beckman L., and Beckman G. p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum Hered 46 (1996) 49-54
22. Yung W.C., Ng M.H., Sham J.S., and Choy D.T. p53 codon 72 polymorphism in nasopharyngeal carcinoma. Cancer Genet Cytogenet 93 (1997) 181-182
23. Tsai M.H., Lin C.D., Hsieh Y.Y., et al. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 112 (2002) 116-119
24. Tiwawech D., Srivatanakul P., Karaluk A., and Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett 198 (2003) 69-75
25. Sousa H., Santos A.M., Catarino R., et al. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev 15 (2006) 362-366
26. Hadhri-Guiga B., Toumi N., Khabir A., et al. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Cancer Genet Cytogenet 178 (2007) 89-93
27. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
28. Matakidou A., Eisen T., and Houlston R.S. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18 (2003) 377-385
29. Zhou Y., Li N., Zhuang W., et al. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 121 (2007) 1481-1486
30. Koushik A., Platt R.W., and Franco E.L. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13 (2004) 11-22
31. Jee S.H., Won S.Y., Yun J.E., Lee J.E., Park J.S., and Ji S.S. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 85 (2004) 301-308
32. Sousa H., Santos A.M., Pinto D., and Medeiros R. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20 (2007) 731-741
33. Pietsch E.C., Humbey O., and Murphy M.E. Polymorphisms in the p53 pathway. Oncogene 25 (2006) 1602-1611
34. Dumont P., Leu J.I., Della Pietra III A.C., George D.L., and Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
35. Chang C.C., Hsieh Y.Y., Tsai F.J., Tsai C.H., Tsai H.D., and Lin C.C. The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 77 (2002) 43-45
36. Katiyar S., Thelma B.K., Murthy N.S., et al. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 252 (2003) 117-124
37. Chen X., Sturgis E.M., El-Naggar A.K., Wei Q., and Li G. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 29 (2008) 2120-2125
38. Nan H., Qureshi A.A., Hunter D.J., and Han J. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk. Br J Dermatol 159 (2008) 314-321